Literature DB >> 12947089

An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection.

Stephen M Smith1, Sara Pentlicky, Zachary Klase, Mahender Singh, Christine Neuveut, Chun-yi Lu, Marvin S Reitz, Robert Yarchoan, Preston A Marx, Kuan-Teh Jeang.   

Abstract

Human and simian immunodeficiency virus (HIV/SIV) Tat proteins are specified by two coding exons. Tat functions in the transcription of primate lentiviruses. A plethora of in vitro data currently suggests that the second coding exon of Tat is largely devoid of function. However, whether the second exon of Tat contributes functionally to viral pathogenesis in vivo remains unknown. To address this question directly, we compared infection of rhesus macaques with an SIV, engineered to express only the first coding exon of Tat (SIVtat1ex), to counterpart infection with wild-type SIVmac239 virus, which expresses the full 2-exon Tat. This comparison showed that the second coding exon of Tat contributes to chronic SIV replication in vivo. Interestingly, in macaques, we observed a cytotoxic T lymphocytes (CTL) response to the second coding exon of Tat, which appears to durably control SIV replication. When SIV mutated in an attempt to escape this second Tat-exon-CTL, the resulting virus was less replicatively fit and failed to populate the host in vivo. Our study provides the first evidence that the second coding exon in Tat embodies an important function for in vivo replication. We suggest the second coding exon of Tat as an example of a functionally constrained "epitope" whose elicited CTL response cannot be escaped by virus mutation without producing a virus that replicates poorly in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12947089     DOI: 10.1074/jbc.M307546200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Stability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region.

Authors:  Xuechao Zhao; Lingyu Qian; Deyu Zhou; Di Qi; Chang Liu; Xiaohong Kong
Journal:  Virol Sin       Date:  2016-03-21       Impact factor: 4.327

Review 2.  Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier.

Authors:  Marianne Strazza; Vanessa Pirrone; Brian Wigdahl; Michael R Nonnemacher
Journal:  Brain Res       Date:  2011-05-14       Impact factor: 3.252

3.  Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon.

Authors:  M R López-Huertas; S Callejas; D Abia; E Mateos; A Dopazo; J Alcamí; M Coiras
Journal:  Nucleic Acids Res       Date:  2010-02-05       Impact factor: 16.971

4.  tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.

Authors:  Raabya Rossenkhan; Iain J MacLeod; Theresa K Sebunya; Eduardo Castro-Nallar; Mary Fran McLane; Rosemary Musonda; Berhanu A Gashe; Vlad Novitsky; M Essex
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

5.  Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.

Authors:  Lakshmi Ramakrishna; Krishnamurthy Kumar Anand; Kumarasamypet M Mohankumar; Udaykumar Ranga
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production.

Authors:  María Rosa López-Huertas; Elena Mateos; María Sánchez Del Cojo; Francisco Gómez-Esquer; Gema Díaz-Gil; Sara Rodríguez-Mora; Juan Antonio López; Enrique Calvo; Guillermo López-Campos; José Alcamí; Mayte Coiras
Journal:  J Biol Chem       Date:  2013-01-30       Impact factor: 5.157

7.  Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.

Authors:  Landhing M Moran; Sylvia Fitting; Rosemarie M Booze; Katy M Webb; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2014-10-05       Impact factor: 2.457

8.  HIV-1 Tat C-terminus is cleaved by calpain 1: implication for Tat-mediated neurotoxicity.

Authors:  Giovanni Passiatore; Slava Rom; Davide Eletto; Francesca Peruzzi
Journal:  Biochim Biophys Acta       Date:  2008-10-31

Review 9.  HIV and Alzheimer's disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein.

Authors:  Alina Hategan; Eliezer Masliah; Avindra Nath
Journal:  J Neurovirol       Date:  2019-04-23       Impact factor: 2.643

10.  Impact of Tat Genetic Variation on HIV-1 Disease.

Authors:  Luna Li; Satinder Dahiya; Sandhya Kortagere; Benjamas Aiamkitsumrit; David Cunningham; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virol       Date:  2012-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.